Sibutramine as a Cause of Sudden Cardiac Death
Author(s) -
Miguel A Rodriguez Guerra,
Mayank Yadav,
Manoj Bhandari,
Archna Sinha,
Jonathan N. Bella,
Eduard Sklyar
Publication year - 2021
Publication title -
case reports in cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 5
eISSN - 2090-6412
pISSN - 2090-6404
DOI - 10.1155/2021/8896932
Subject(s) - sibutramine , medicine , sudden cardiac death , autopsy , acute coronary syndrome , cardiology , sudden death , adverse effect , disease , weight loss , obesity , myocardial infarction
Importance. Sibutramine was withdrawn from the US market due to association with adverse cardiovascular outcomes especially with patients having preexisting cardiac disease. However, continued presence of sibutramine in herbal medications is a concern to public safety. Results. We report a case of a patient with no evidence of previous coronary heart disease, who presented with non-ST elevation acute coronary syndrome (NSTE-ACS). Urgent coronary catheterization showed nonobstructive coronaries. However, patient died unexpectedly within 24 hours of admission. The patient denied toxic habits but was taking over-the-counter weight loss herbal supplements. Complete autopsy was performed which showed sibutramine in the toxicology. Patient died due to complications of acute inadvertent intoxication of sibutramine. Conclusion and Relevance. This is the first case report in literature showing association of sibutramine to sudden cardiac death in patients with no prior cardiac history. The continued presence of sibutramine in some over-the-counter weight loss formulations is a very concerning public health issue.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom